Bipolar disorder (BD) is characterized by recurrent mood episodes, and circadian rhythm disturbances. Past studies have identified calcium channel genes as risk loci for BD. CACNA1C encodes an L-type calcium channel (LTCC) involved in the entrainment of circadian rhythms to light. Another calcium channel, i.e., the ryanodine receptor (RYR), is involved in -circadian phase delays. It is unknown whether variants in CACNA1C or other calcium channels contribute to the circadian phenotype in BD. We hypothesized that, by using temperature cycles, we could model circadian entrainment in fibroblasts from BD patients and controls to interrogate the circadian functions of LTCCs. Using Per2-luc, a bioluminescent reporter, we verified that cells entrain to temperature rhythms in vitro. Under constant temperature conditions, the LTCC antagonist verapamil shortened the circadian period, and the RYR antagonist dantrolene lengthened the period. However, neither drug affected temperature entrainment. Fibroblasts from BD patients and controls also entrained to temperature. In cells from BD patients, the rhythm amplitude was lower under entrained, but not constant, conditions. Temperature entrainment was otherwise similar between BD and control cells. However, the CACNA1C genotype among BD cells predicted the degree to which cells entrained. We conclude that assessment of rhythms under entrained conditions reveals additional rhythm abnormalities in BD that are not observable under constant temperature conditions.

1.
McGuffin
P
,
Rijsdijk
F
,
Andrew
M
,
Sham
P
,
Katz
R
,
Cardno
A
.
The heritability of bipolar affective disorder and the genetic relationship to unipolar depression
.
Arch Gen Psychiatry
.
2003
May
;
60
(
5
):
497
502
.
[PubMed]
0003-990X
2.
Psychiatric GWAS Consortium Bipolar Disorder Working Group
.
Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4
.
Nat Genet
.
2011
Sep
;
43
(
10
):
977
83
.
[PubMed]
1061-4036
3.
Cross-Disorder Group of the Psychiatric Genomics Consortium
.
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis
.
Lancet
.
2013
Apr
;
381
(
9875
):
1371
9
.
[PubMed]
0140-6736
4.
Mertens
J
,
Wang
QW
,
Kim
Y
,
Yu
DX
,
Pham
S
,
Yang
B
, et al.;
Pharmacogenomics of Bipolar Disorder Study
.
Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder
.
Nature
.
2015
Nov
;
527
(
7576
):
95
9
.
[PubMed]
0028-0836
5.
Nurnberger
JI
 Jr
,
Koller
DL
,
Jung
J
,
Edenberg
HJ
,
Foroud
T
,
Guella
I
, et al.;
Psychiatric Genomics Consortium Bipolar Group
.
Identification of pathways for bipolar disorder: a meta-analysis
.
JAMA Psychiatry
.
2014
Jun
;
71
(
6
):
657
64
.
[PubMed]
2168-622X
6.
McCarthy
MJ
,
Welsh
DK
.
Cellular circadian clocks in mood disorders
.
J Biol Rhythms
.
2012
Oct
;
27
(
5
):
339
52
.
[PubMed]
0748-7304
7.
Harvey
AG
.
Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation
.
Am J Psychiatry
.
2008
Jul
;
165
(
7
):
820
9
.
[PubMed]
0002-953X
8.
Pagani
L
,
St Clair
PA
,
Teshiba
TM
,
Service
SK
,
Fears
SC
,
Araya
C
, et al.
Genetic contributions to circadian activity rhythm and sleep pattern phenotypes in pedigrees segregating for severe bipolar disorder
.
Proc Natl Acad Sci USA
.
2016
Feb
;
113
(
6
):
E754
61
.
[PubMed]
0027-8424
9.
Gonzalez
R
,
Tamminga
CA
,
Tohen
M
,
Suppes
T
.
The relationship between affective state and the rhythmicity of activity in bipolar disorder
.
J Clin Psychiatry
.
2014
Apr
;
75
(
4
):
e317
22
.
[PubMed]
0160-6689
10.
McCarthy
MJ
,
Wei
H
,
Marnoy
Z
,
Darvish
RM
,
McPhie
DL
,
Cohen
BM
, et al.
Genetic and clinical factors predict lithium’s effects on PER2 gene expression rhythms in cells from bipolar disorder patients
.
Transl Psychiatry
.
2013
Oct
;
3
(
10
):
e318
.
[PubMed]
2158-3188
11.
McCarthy
M
,
Wei
H
,
Nievergelt
C
,
Stautland
A
,
Maihofer
A
.
DK W: Chronotype and Cellular Circadian Rhythms Predict the Clinical Response to Lithium Maintenance Treatment in Patients with Bipolar Disorder
.
Neuropsychopharmacology
.
2018
.0893-133X
12.
McCarthy
MJ
,
Wei
H
,
Landgraf
D
,
Le Roux
MJ
,
Welsh
DK
.
Disinhibition of the extracellular-signal-regulated kinase restores the amplification of circadian rhythms by lithium in cells from bipolar disorder patients
.
Eur Neuropsychopharmacol
.
2016
Aug
;
26
(
8
):
1310
9
.
[PubMed]
0924-977X
13.
McCarthy
MJ
,
LeRoux
M
,
Wei
H
,
Beesley
S
,
Kelsoe
JR
,
Welsh
DK
.
Calcium channel genes associated with bipolar disorder modulate lithium’s amplification of circadian rhythms
.
Neuropharmacology
.
2015
.
[PubMed]
0028-3908
14.
Kim
DY
,
Choi
HJ
,
Kim
JS
,
Kim
YS
,
Jeong
DU
,
Shin
HC
, et al.
Voltage-gated calcium channels play crucial roles in the glutamate-induced phase shifts of the rat suprachiasmatic circadian clock
.
Eur J Neurosci
.
2005
Mar
;
21
(
5
):
1215
22
.
[PubMed]
0953-816X
15.
Pfeffer
M
,
Müller
CM
,
Mordel
J
,
Meissl
H
,
Ansari
N
,
Deller
T
, et al.
The mammalian molecular clockwork controls rhythmic expression of its own input pathway components
.
J Neurosci
.
2009
May
;
29
(
19
):
6114
23
.
[PubMed]
0270-6474
16.
Gamble
KL
,
Ciarleglio
CM
.
Ryanodine receptors are regulated by the circadian clock and implicated in gating photic entrainment
.
J Neurosci
.
2009
Sep
;
29
(
38
):
11717
9
.
[PubMed]
0270-6474
17.
Ding
JM
,
Buchanan
GF
,
Tischkau
SA
,
Chen
D
,
Kuriashkina
L
,
Faiman
LE
, et al.
A neuronal ryanodine receptor mediates light-induced phase delays of the circadian clock
.
Nature
.
1998
Jul
;
394
(
6691
):
381
4
.
[PubMed]
0028-0836
18.
Schmutz
I
,
Chavan
R
,
Ripperger
JA
,
Maywood
ES
,
Langwieser
N
,
Jurik
A
, et al.
A specific role for the REV-ERBα-controlled L-Type Voltage-Gated Calcium Channel CaV1.2 in resetting the circadian clock in the late night
.
J Biol Rhythms
.
2014
Aug
;
29
(
4
):
288
98
.
[PubMed]
0748-7304
19.
Obrietan
K
,
Impey
S
,
Storm
DR
.
Light and circadian rhythmicity regulate MAP kinase activation in the suprachiasmatic nuclei
.
Nat Neurosci
.
1998
Dec
;
1
(
8
):
693
700
.
[PubMed]
1097-6256
20.
Partch
CL
,
Green
CB
,
Takahashi
JS
.
Molecular architecture of the mammalian circadian clock
.
Trends Cell Biol
.
2014
Feb
;
24
(
2
):
90
9
.
[PubMed]
0962-8924
21.
Brown
SA
,
Zumbrunn
G
,
Fleury-Olela
F
,
Preitner
N
,
Schibler
U
.
Rhythms of mammalian body temperature can sustain peripheral circadian clocks
.
Curr Biol
.
2002
Sep
;
12
(
18
):
1574
83
.
[PubMed]
0960-9822
22.
Buhr
ED
,
Yoo
SH
,
Takahashi
JS
.
Temperature as a universal resetting cue for mammalian circadian oscillators
.
Science
.
2010
Oct
;
330
(
6002
):
379
85
.
[PubMed]
0036-8075
23.
Oedegaard
KJ
,
Alda
M
,
Anand
A
,
Andreassen
OA
,
Balaraman
Y
,
Berrettini
WH
, et al.
The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample
.
BMC Psychiatry
.
2016
May
;
16
(
1
):
129
.
[PubMed]
1471-244X
24.
Gingerich
S
,
Kim
GL
,
Chalmers
JA
,
Koletar
MM
,
Wang
X
,
Wang
Y
, et al.
Estrogen receptor α and G-protein coupled receptor 30 mediate the neuroprotective effects of 17β-estradiol in novel murine hippocampal cell models
.
Neuroscience
.
2010
Sep
;
170
(
1
):
54
66
.
[PubMed]
0306-4522
25.
Barrett
RK
,
Takahashi
JS
.
Lability of circadian pacemaker amplitude in chick pineal cells: a temperature-dependent process
.
J Biol Rhythms
.
1997
Aug
;
12
(
4
):
309
18
.
[PubMed]
0748-7304
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.